Page last updated: 2024-10-29

iomeprol and Carcinoma, Bronchogenic

iomeprol has been researched along with Carcinoma, Bronchogenic in 2 studies

iomeprol: structure given in first source
iomeprol : A benzenedicarboxamide compound having N-substituted carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and a glycoloyl(methyl)amino group at the 5-position.

Carcinoma, Bronchogenic: Malignant neoplasm arising from the epithelium of the BRONCHI. It represents a large group of epithelial lung malignancies which can be divided into two clinical groups: SMALL CELL LUNG CANCER and NON-SMALL-CELL LUNG CARCINOMA.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ohlmann, S1
Nowak, R1
Daliri, A1
Michulla, R1
Froelich, JJ1
Kiessling, F1
Boese, J1
Corvinus, C1
Ederle, JR1
Zuna, I1
Schoenberg, SO1
Brix, G1
Schmähl, A1
Tuengerthal, S1
Herth, F1
Kauczor, HU1
Essig, M1

Other Studies

2 other studies available for iomeprol and Carcinoma, Bronchogenic

ArticleYear
[Refined staging in Hilar bronchial neoplasms with ECG-gated multislice-CT---case report].
    Rontgenpraxis; Zeitschrift fur radiologische Technik, 2008, Volume: 56, Issue:5

    Topics: Aged; Bronchi; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cardiac-Gat

2008
Perfusion CT in patients with advanced bronchial carcinomas: a novel chance for characterization and treatment monitoring?
    European radiology, 2004, Volume: 14, Issue:7

    Topics: Adult; Aged; Carcinoma, Bronchogenic; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Contras

2004